Shu-chih Chen - Net Worth and Insider Trading
Shu-chih Chen Net Worth
The estimated net worth of Shu-chih Chen is at least $34,303 dollars as of 2024-05-28. Shu-chih Chen is the Director, 10% Owner of Atossa Therapeutics Inc and owns about 24,157 shares of Atossa Therapeutics Inc (ATOS) stock worth over $34,303. Details can be seen in Shu-chih Chen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shu-chih Chen has not made any transactions after 2016-03-09 and currently still holds the listed stock(s).
Transaction Summary of Shu-chih Chen
Shu-chih Chen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shu-chih Chen owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .
Click here to see the complete history of Shu-chih Chen’s form 4 insider trades.
Insider Ownership Summary of Shu-chih Chen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2016-03-09 | director & 10 percent owner & Chief Scientific Officer |
Shu-chih Chen Latest Holdings Summary
Shu-chih Chen currently owns a total of 1 stock. Shu-chih Chen owns 24,157 shares of Atossa Therapeutics Inc (ATOS) as of March 9, 2016, with a value of $34,303.
Latest Holdings of Shu-chih Chen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2016-03-09 | 24,157 | 1.42 | 34,303 |
Holding Weightings of Shu-chih Chen
Shu-chih Chen Form 4 Trading Tracker
According to the SEC Form 4 filings, Shu-chih Chen has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 83 shares on March 9, 2016, which cost Shu-chih Chen around $5,550.
Insider Trading History of Shu-chih Chen
- 1
Shu-chih Chen Trading Performance
GuruFocus tracks the stock performance after each of Shu-chih Chen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shu-chih Chen is -5.45%. GuruFocus also compares Shu-chih Chen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shu-chih Chen within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shu-chih Chen's insider trading performs compared to the benchmark.
Performance of Shu-chih Chen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 41.06 | | | | | |
| Relative Return to S&P 500(%) | 37.12 | | | | | |
Shu-chih Chen Ownership Network
Shu-chih Chen Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Shu-chih Chen is the director & 10 percent owner & Chief Scientific Officer of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & CEO Steven C Quay .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Shu-chih Chen made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Shu-chih Chen Mailing Address
Above is the net worth, insider trading, and ownership report for Shu-chih Chen. You might contact Shu-chih Chen via mailing address: C/o Atossa Genetics, Inc, 4105 E Madison Street, Suite 320, Seattle Wa 98112.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
